In the context of breast cancer, PARP12 has been identified as an active participant in the IFN–STAT1 signaling pathway, which promotes survival and regrowth of breast cancer cells after chemotherapy (Gaston et al., 2016). Here, IFNA1 is linked to breast carcinoma.